Teladoc (TDOC) Moves 6.1% Higher: Will This Strength Last?
Werte in diesem Artikel
Teladoc (TDOC) shares rallied 6.1% in the last trading session to close at $8.39. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 5.3% gain over the past four weeks.TDOC shares climbed last Friday as investors remained optimistic about the company's growth prospects. The company's continued focus on expanding its virtual care platform, improving operational efficiency and maintaining financial discipline has strengthened confidence in its turnaround strategy. Expectations for better margins, healthier cash flow generation and a more sustainable business model are also supporting positive sentiment toward the stock.This telehealth services provider is expected to post quarterly loss of $0.24 per share in its upcoming report, which represents a year-over-year change of -26.3%. Revenues are expected to be $614.69 million, down 2.7% from the year-ago quarter.While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For Teladoc, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on TDOC going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Teladoc is part of the Zacks Medical Services industry. SkinHealth Systems Inc. (SKIN), another stock in the same industry, closed the last trading session 3.2% higher at $0.66. SKIN has returned -18.6% in the past month.For SkinHealth Systems Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.03. This represents a change of -200% from what the company reported a year ago. SkinHealth Systems Inc. currently has a Zacks Rank of #2 (Buy).Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.See Stocks Now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Teladoc und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Teladoc
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Teladoc
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Teladoc Inc
Analysen zu Teladoc Inc
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.11.2018 | Teladoc Buy | Chardan Capital Markets | |
| 03.08.2018 | Teladoc Buy | Chardan Capital Markets | |
| 05.06.2018 | Teladoc Buy | Canaccord Adams | |
| 15.03.2018 | Teladoc Hold | Deutsche Bank AG | |
| 28.02.2018 | Teladoc Buy | Chardan Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.11.2018 | Teladoc Buy | Chardan Capital Markets | |
| 03.08.2018 | Teladoc Buy | Chardan Capital Markets | |
| 05.06.2018 | Teladoc Buy | Canaccord Adams | |
| 28.02.2018 | Teladoc Buy | Chardan Capital Markets | |
| 08.12.2017 | Teladoc Buy | Deutsche Bank AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.03.2018 | Teladoc Hold | Deutsche Bank AG | |
| 18.09.2017 | Teladoc Neutral | Robert W. Baird & Co. Incorporated |
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Teladoc Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen